Can you pitch a stock as a long if all brokers rate "Buy" and still be differentiated?

I want to pitch a smaller pharma stock (EV: Less than $5bn), but valuations are severely depressed at the moment and price targets are really high for many quality names in the universe I am looking at. Given stock prices are not reflecting the merits of some of these companies, can I anchor on a catalyst and why it should not only increase earnings, but also hopefully spark multiple expansion leading to a positive stock move? Thinking perhaps I could be differentiated in that I have stronger conviction than brokers as to the positive effect of catalysts. I was also thinking I could theorize that there is really small downside risk so my average expected return across bull, base and bear cases will be very attractive. 


Based on the WSO content, pitching a stock as a long even when all brokers rate it as "Buy" can indeed be differentiated if you focus on unique insights or a deeper conviction about specific catalysts that others might have overlooked or underestimated. Here’s how you can structure your pitch to make it stand out:

  1. Deep Dive into the Catalysts: Identify and elaborate on specific catalysts that could drive the stock price. This could include upcoming FDA approvals, positive trial results, or new product launches. Explain why these catalysts are significant and how they might be undervalued or misunderstood by the market.

  2. Strong Conviction on Catalysts: Highlight your stronger conviction in the effectiveness and impact of these catalysts compared to the general market or broker opinions. Provide data or research that supports your belief in the potential of these catalysts to not only increase earnings but also to drive multiple expansion.

  3. Valuation Analysis: Discuss the current valuation metrics and how they compare to historical averages or sector peers. Explain why you believe the stock is undervalued and how the catalysts you’ve identified could correct this undervaluation. Include potential scenarios where these catalysts lead to a re-rating of the stock.

  4. Risk Assessment: Address the potential risks and why you see limited downside. This could involve discussing the company’s financial health, market position, or the robustness of its pipeline. Show how these factors support a low-risk profile and contribute to an attractive risk/reward ratio.

  5. Comparative Analysis: If possible, compare the expected impact of the catalysts on your chosen stock with other stocks in the same sector that might not have similar positive triggers. This comparison can help in illustrating why your chosen stock could outperform.

  6. Investment Thesis Summary: Summarize your investment thesis with clear, concise points that reinforce your unique perspective and strong conviction. Highlight how your analysis leads to a different conclusion than the consensus view despite the "Buy" ratings.

By focusing on these elements, you can craft a differentiated pitch that not only supports a long position but also showcases your deep understanding and unique insights into the stock and its potential catalysts.

Sources: Stock Pitch Sample Template - Proven Examples to Help Ace Your Interview, How do you nail the "wow factor" in a pitch?, A Guide on How to Navigate On-Cycle PE Recruiting, Stock Pitch Sample Template - Proven Examples to Help Ace Your Interview, Guide To Evaluate a Biotech Company

I'm an AI bot trained on the most helpful WSO content across 17+ years.
Most Helpful

Voluptatum repellendus perferendis deserunt culpa iure esse. Quia sequi sint rem ut soluta enim voluptates. Sunt explicabo veniam porro eius. Qui et expedita quas quasi similique voluptatem. Minima omnis error qui ratione perferendis commodi. Dicta tempora consectetur et saepe nulla exercitationem dolore.

Illum ut est magni et repudiandae voluptas. Dicta voluptas dolorum sed assumenda magnam non. Minima doloribus voluptates non voluptas dignissimos animi rerum.

Et sunt minima alias nulla aut. Et rem laboriosam corrupti quae incidunt laudantium. Nobis voluptate velit id voluptas assumenda numquam voluptas. Placeat voluptatem possimus quae error sapiente. Quisquam omnis omnis et quia.

Enim delectus deserunt sint id autem amet in. Sit minus vel dolores quasi. Ratione reiciendis voluptas totam.

Career Advancement Opportunities

May 2024 Hedge Fund

  • Point72 98.9%
  • D.E. Shaw 97.9%
  • Citadel Investment Group 96.8%
  • Magnetar Capital 95.8%
  • AQR Capital Management 94.7%

Overall Employee Satisfaction

May 2024 Hedge Fund

  • Magnetar Capital 98.9%
  • D.E. Shaw 97.8%
  • Blackstone Group 96.8%
  • Two Sigma Investments 95.7%
  • Citadel Investment Group 94.6%

Professional Growth Opportunities

May 2024 Hedge Fund

  • AQR Capital Management 99.0%
  • Point72 97.9%
  • D.E. Shaw 96.9%
  • Magnetar Capital 95.8%
  • Citadel Investment Group 94.8%

Total Avg Compensation

May 2024 Hedge Fund

  • Portfolio Manager (9) $1,648
  • Vice President (23) $474
  • Director/MD (12) $423
  • NA (6) $322
  • 3rd+ Year Associate (24) $287
  • Manager (4) $282
  • Engineer/Quant (71) $274
  • 2nd Year Associate (30) $251
  • 1st Year Associate (73) $190
  • Analysts (225) $179
  • Intern/Summer Associate (23) $131
  • Junior Trader (5) $102
  • Intern/Summer Analyst (251) $85
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”


redever's picture
BankonBanking's picture
Secyh62's picture
Betsy Massar's picture
Betsy Massar
dosk17's picture
kanon's picture
GameTheory's picture
CompBanker's picture
DrApeman's picture
numi's picture
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”